AstraZeneca

AstraZeneca plc is a global pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, England. It is owned by the British and the Swedish governments. It has a portfolio of products for important illnesses in areas like oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It helped make the COVID-19 vaccine that was created by Oxford and AstraZeneca.

In 1999, the Swedish Astra AB and the British Zeneca Group joined to form the company. The British Zeneca Group was created in 1993 when the pharmaceutical business of Imperial Chemical Industries was split into a separate company. Since the merger, it has become one of the biggest pharmaceutical companies in the world and has bought many other companies, including Cambridge Antibody Technology (2006), MedImmune (2007), Spirogen (2013), and Definiens (2014), which was bought by MedImmune. It does most of its research and development in three key places: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, in the United States.

AstraZeneca is listed on the London Stock Exchange as its main float and part of the FTSE 100 Index.

Founded: 1999

Headquarters: Cambridge, England, UK

Website: https://www.astrazeneca.com/